RhoA/Rho‐kinases in asthma: from pathogenesis to therapeutic targets is a research paper published in Clinical & Translational Immunology (2020). On theSindex it has a DataRank of 0. It has been cited 65 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIAID NIH HHS
Grant: R56 AI143668
NIAID NIH HHS
Grant: R01 AI141642
NIAID NIH HHS
Grant: R21 AI137547
NIEHS NIH HHS
Grant: R56 ES021739
NIAID NIH HHS
Grant: R01 AI153331
National Institutes of Health
Grant: 1R21AI137547-01
Regulation of allergen-induced mast cell activation and allergic inflammation through DCIR
National Institutes of Health
Grant: 5R01AI141642-04
Environmental Pollutants Potentiate Allergic Inflammation via Functional Axis of Aryl hydrocarbon Receptor, ROS, and CaMKII in Asthma
National Institutes of Health
Grant: 2R56ES021739-06
miR-511-3p, a therapeutic target for allergic asthma
National Institutes of Health
Grant: 1R56AI143668-01
RhoA signaling controls mesenchymal stem cell lineage commitment via Lef-1 in asthma
FWCI
2.91
Citation Percentile
0.9%
Influential Citations
3
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals
Additional file 1 of Targeting of G-protein coupled receptor 40 alleviates airway hyperresponsiveness through RhoA/ROCK1 signaling pathway in obese asthmatic mice
Additional file 1 of Targeting of G-protein coupled receptor 40 alleviates airway hyperresponsiveness through RhoA/ROCK1 signaling pathway in obese asthmatic mice